Understanding the science market

Science Industry Australia

Tuesday, 12 August, 2014

Australian Science Industry Exchange (ASiX) is a one-day event for companies that supply equipment or services to the Australian science sector - including defence, research, CSIRO and more.

Opened by Australia’s Chief Scientist Prof Ian Chubb, and with presentations from a host of experts including Dr Cathy Foley (CSIRO), Prof Aidan Byrne (ARC), Dr Anna Lavelle (AusBiotech) and Prof Warwick Anderson (NHMRC), this event will give attendees an overview on the current economic outlook as well as possible future trends in the industry and make sure they are up to date with all the regulatory and legislative changes that affect both customers and suppliers.

What you will learn by attending:

  • Changing needs and buying behaviours of your customers
  • What your customers really want
  • Policy and funding initiatives from government
  • Regulatory/legislative changes and updates that affect your company
  • How to engage successfully with major client organisations
  • What’s on the horizon?

Customers from research, defence and CSIRO will explain what they need and how they like to interact with their suppliers so you will be equipped to meet their requirements and promote your products and company more effectively.

The full program can be seen here.

Both full- and half-day tickets are available.

Discounted tickets are available for SIA, ALMA and CRCA members.

When: Wednesday, 20 August 2014 from 8.30 am to 5.30 pm EST
Where: Rydges Hotel Bell City, 215 Bell Street, Preston 3072
More information: Duncan Jones, Science Industry Australia Ltd, (03) 9872 5111, conferences@scienceindustry.com.au

Related News

3D-printed films provide targeted liver cancer treatment

Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer...

Using your brain at work may ward off cognitive impairment

The harder your brain works at your job, the less likely you may be to have memory and thinking...

Repurposed drugs show promise in heart muscle regeneration

The FDA-approved medications, when given in combination, target two proteins that regulate the...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd